Registered Members Login:
   
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

4715 Pages (Click to Jump) V  « < 382 383 384 385 386 387 388 > »    
 
  
Reply to this topic

CUV, CLINUVEL PHARMACEUTICALS LIMITED
Verharven
post Posted: Mar 6 2019, 05:23 AM
  Quote Post


Posts: 804
Thanks: 2063


In Reply To: NewToCli's post @ Mar 5 2019, 11:30 PM

AFR reading hack - hit 'escape' before the page fully loads and voila!

In other news, on high volume, Germany closed at EUR 17.35 ($27.68) and the US at USD 19.40 (AUD 27.37)


Said 'Thanks' for this post: sharelooker  
 
KRD
post Posted: Mar 6 2019, 04:48 AM
  Quote Post


Posts: 1,118
Thanks: 1609


In Reply To: LevelHeaded2000's post @ Mar 6 2019, 04:32 AM

Pick a good bottle; could be this week. CLVLY on a good trajectory today.

 
LevelHeaded2000
post Posted: Mar 6 2019, 04:32 AM
  Quote Post


Posts: 404
Thanks: 943


When Clinuvel hits $20.00 USD, no matter the day, I will be drinking a bottle of wine. I hope that my fellow investors will be joining me. Cheers to a good company creating a life-changing product that will hopefully bring joy and happiness to patients and investors alike.


Said 'Thanks' for this post: gerritbakker57  sharelooker  xlnja  royco  johnnytech  endymion96  CobiV13  
 
NewToCli
post Posted: Mar 6 2019, 02:30 AM
  Quote Post


Posts: 735
Thanks: 1397


Ur9 ticking up every minute .. 17.33 eur ATH


Said 'Thanks' for this post: gerritbakker57  mrdax  
 
PunkassDerm
post Posted: Mar 5 2019, 11:41 PM
  Quote Post


Posts: 519
Thanks: 1396


Awesome! ...as long as it "pays off in the end," for all

Rich Bosses 2019: Meet Australia's 10 wealthiest executives
James Thomson
Mar 5, 2019 — 11.00pm

Canny investors have long believed that backing executives with skin in the game is a winning strategy. The 2019 Rich Bosses list is more proof of that strategy.
The list ranks managers and executive directors from companies in the ASX 300 according to value of the business they work in.
The full list, which was last year topped by Seven Group executive chairman Kerry Stokes, will be published in Boss magazine in Friday's edition of The Australian Financial Review.

.........

Clinuvel Pharmaceutical

Another strong performer was Clinuvel Pharmaceuticals, which produced a total shareholder return of 151 per cent in the year in question.
The biotechnology firm focused on developing treatments for a range of severe genetic and skin disorders; it's flagship drug Scenesse is in trials in the United States and Europe.
The company's chief executive, Philippe Wolgen, is a former life sciences equity analyst with deep experience in European financial markets; he has a stake worth $72 million and had total remuneration of $2.3 million in the 2018 financial year.


Said 'Thanks' for this post: NewToCli  johnnytech  
 
NewToCli
post Posted: Mar 5 2019, 11:30 PM
  Quote Post


Posts: 735
Thanks: 1397


In Reply To: odi01's post @ Mar 5 2019, 10:25 PM

Need to subscribe to read it ... they mention PW? smile.gif

 


odi01
post Posted: Mar 5 2019, 10:25 PM
  Quote Post


Posts: 631
Thanks: 1451


https://www.afr.com/business/rich-bosses-20...20190304-h1bz1a


Said 'Thanks' for this post: PunkassDerm  
 
seeva222
post Posted: Mar 5 2019, 06:45 AM
  Quote Post


Posts: 1,353
Thanks: 1451


In Reply To: NewToCli's post @ Mar 5 2019, 06:14 AM

This is the big Kahuna. Anti-oxident, anti-inflammatory properties + OTC will get Walnut a real footy team.


Said 'Thanks' for this post: Doogieson  NewToCli  
 
NewToCli
post Posted: Mar 5 2019, 06:14 AM
  Quote Post


Posts: 735
Thanks: 1397


In Reply To: PunkassDerm's post @ Mar 5 2019, 04:11 AM

The anti oxidant effect of Scenesse might even be the bigger benefit for the EPP sufferers than the pigmentation of the skin.

Regarding asx200 and the investor presentation:

Let’s remember to read between the lines with the cuv communication:

August 21, 2018; Clinuvel Investor Presentation
September 07, 2018: ASX300 quarterly rebalancing

Quite a good hint cuv might well be including in the asx200


Said 'Thanks' for this post: sharelooker  Farleap11  macgyver  waz  ajshare  
 
PunkassDerm
post Posted: Mar 5 2019, 04:11 AM
  Quote Post


Posts: 519
Thanks: 1396


In Reply To: royco's post @ Mar 5 2019, 04:08 AM

I agreed wholeheartedly. The free radial protection alone is anti-aging/anti-cancer.

I think shareholders of note should have access to 4x yearly implants, sign me up.

Frilly Frilly


Said 'Thanks' for this post: johnnytech  waz  Doogieson  
 
 


4715 Pages (Click to Jump) V  « < 382 383 384 385 386 387 388 > » 

Back To Top Of Page
Reply to this topic


You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.


TERMS OF USE  -  CONTACT ADMIN  -  ADVERTISING